Body weight, estrogen and cognitive functioning in Alzheimer's disease: An analysis of the Tacrine Study Group Data

Archives of Gerontology and Geriatrics

Volumn 24, Issue 3, 1997, Pages 261-267

  Buckwalter, J Galen ^a   Schneider, Lon S ^b,c   Wilshire, Thea W ^d   Dunn, Meleana E ^c   Henderson, Victor W ^a,b,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d FULLER THEOLOGICAL SEMINARY   (United States)

Author keywords

Alzheimer's disease; Cognition; Estrogen; Tacrine; Weight

Indexed keywords

CHOLINESTERASE INHIBITOR; ESTROGEN; TACRINE;

AGED; ALZHEIMER DISEASE; ARTICLE; BODY HEIGHT; BODY WEIGHT; COGNITION; CONTROLLED STUDY; DISEASE DURATION; EDUCATION; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE;

EID: 0030894424     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(96)00763-7     Document Type: Article

References (35)

1. Bartus, R.T., Dean, R.L., Pontecorvo, M.J. and Flicker, C. (1985): The cholinergic hypothesis: a historical overview, current perspective, and future directions. Ann. N.Y. Acad. Sci., 444, 332-358.
2. Brenner, D.E., Kukull, W.A., Stergachis, A., Van Belle, G., Bowen, J.D., McCormick, W.C., Teri, L. and Larson, E.B. (1994): Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am. J. Epidemiol., 140, 262-267.
3. Coyle, J.T., Price, D.L. and DeLong, M.R. (1983): Alzheimer's disease: a disorder of cortical cholinergic innervation. Science, 219, 1184-1190.
4. Fillet, H., Weinreb, H., Cholst, I., Luine, V., McEwen, B., Amador, R. and Zabriskie, J. (1986): Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology, 11, 337-345.
5. Folstein, M.F., Folstein, S.E., and McHugh, P.R. (1975): 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res., 12, 189-198.
6. Gould, E., Woolley, C.S., Frankfurt, M. and McEwen, B.S. (1990): Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J. Neurosci., 10, 1286-1291.
7. Haffner, S.M.. Valdez, R.A., Stern, M.P. and Katz, M.S. (1993): Obesity, body fat distribution and sex hormones in men. Int. J. Obesity, 17, 643-649.
8. Henderson, V.W., Paganini-Hill, A., Emanuel, C.K., Dunn, M.E. and Buckwalter, J.G. (1994): Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and nondemented controls. Arch. Neurol., 51, 896-900.
9. Henderson, V.W., Watt, L.E., and Buckwalter, J.G. (1996): Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychneuroendocrinology, 21, 421-430.
10. Honjo, H. and Ogeno, Y. (1993): An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: a placebo-controlled double-blind study. J. Jpn. Menopause Soc., 1, 167-171.
11. Honjo, H., Ogeno, Y., Naitoh, K., Urabe, M., Kitawaki, J., Yasuda, J., Yamamoto, T., Ishihara, S., Okada, H., Yonezawa, T., Hayashi, K. and Nambara, T. (1989): In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer'stype). J. Steroid Biochem., 34, 521-525.
12. Janowsky, J.S., Oviatt, S.K. and Orwoll, E.S. (1994): Testosterone influences spatial cognition older men. Behav. Neurosci., 108, 325-332.
13. Kirschner, M.A., Schneider, G., Ertel, H.H. and Worton, E. (1982): Obesity, androgens, estrogens, and cancer risk. Cancer Res., 42 (Suppl.), 3281s-3285s.
14. Knapp, M.J., Knopman, D.S., Soloman, P.R., Pendlebury, W.W., Davis, C.S. and Gracon, S.I. for the Tacrine Study Group. (1994): A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. J Am. Med. Assoc., 271, 985-991.
15. Lindsay, R. (1993): Criteria for successful estrogen therapy in osteoporosis. Osteoporosis Int., 3 (Suppl. 2), s9-s12.
16. Luine, V. (1985): Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol., 89, 484-490.
17. Luine, V.M. and McEwen, B.S. (1983): Sex differences in cholinergic enzymes of diagonal band nuclei in the rat preoptic area. Neuroendocrinology, 36, 475-482.
18. McGeer, P.L., McGeer, E.G., Suzuki, J., Dolman, C.E. and Nagai, T. (1984): Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology, 34, 741-745.
19. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M. (1984): Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzhiemer's Disease. Neurology, 34, 939-944.
20. Meldrum, D.R., Davidson, B.J., Tataryn, I.V. and Judd, H.L. (1981): Changes in circulating steroids with aging in postmenopausal women. Obstet. Gynecol., 57, 624-628.
21. Mortel, K.F. and Meyer, J.S. (1995): Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J. Neuropsychiatry Clin. Neurosci., 7, 334-337.
22. Ohkura, R., Isse, K., Akazawa, K., Hamamoto, M., Yaoi, Y. and Hagino, N. (1994): Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocrinol. J., 41, 361-371.
23. Paganini-Hill, A. and Henderson, V.W. (1994): Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol., 140, 256-261.
24. Paganini-Hill, A., Ross, R.K., Gerkins, V.R., Henderson, B.E., Arthur, M. and Mack, T.M. (1981): Menopausal estrogen therapy and hip fractures. Ann. Intern. Med., 95, 28-31.
25. Pasquali, R., Casimirri, F., Cantobelli, S., Melchionda, N., Labate, A.M.M., Fabbri, R., Capelli, M. and Bortoluzzi, L. (1991): Effect of obesity and body fat distribution on sex hormoness and insulin in men. Metabolism, 40, 101-104.
26. Persson, I., Naessen, T., Adami, H.O., Bergstrom, R., Lagrelius, A., Mollerstrom, G., Peterson, B. and Von Hamos, K. (1992): Reduced risk of hip fracture in women with endometrial cancer. Int. J. Epidemiol., 21, 636-642.
27. Robbins, L.J. (1989): Evaluation of weight loss in the elderly. Geriatrics, 44, 31-34.
28. Rosen, W.G., Mohs, R.C. and Davis, K.L. (1984): A new rating scale for Alzheimer's disease. Am. J. Psychiatry, 141, 1356-1364.
29. Schneider, G., Kirschner, M.A., Berkowitz, R. and Ertel, N.H. (1979): Increased estrogen production in obese men. J. Clin. Endocrinol. Metab., 48, 633-638.
30. Singh, S., Mulley, G.P. and Losowsky, M.S. (1988): Why are Alzheimer's patients thin? Age Ageing, 17, 21-28.
31. Tan, U. (1990): Testosterone and nonverbal intelligence in right-handed men and women. Int. J. Neurosci., 54, 277-282.
32. Tan, U. and Akgun, A. (1992): There is a direct relationship between nonverbal intelligence and serum testosterone level in young men. Int. J. Neurosci., 64, 213-216.
33. Tremollieres, F.A., Pouilles, J.M. and Ribot, C. (1993): Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women. J. Clin. Endocrinol. Metab., 77, 683-686.
34. Van Beresteijn, E.C.H., Van Laarhoven, J.P.R.M. and Smals, A.G.H. (1992): Body weight and/or endogenous estradiol as determinants of cortical bone mass and bone loss in healthy early postmenopausal women. Acta Endocrinol., 127, 226-230.
35. Wolf-Klein, G.P., Silverstone, F.A. and Levy, A.P. (1992): Nutritional patterns and weight change in Alzheimer's patients. Int. Psychogeriatrics, 4, 103-118.